| Influence of diet on the gut microbiome and implications for human health RK Singh, HW Chang, DI Yan, KM Lee, D Ucmak, K Wong, M Abrouk, ... Journal of translational medicine 15, 1-17, 2017 | 2489 | 2017 |
| Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression J Koo, LB Marangell, M Nakamura, A Armstrong, C Jeon, T Bhutani, ... Journal of the European Academy of Dermatology and Venereology 31 (12), 1999 …, 2017 | 202 | 2017 |
| The role of IL-17 in vitiligo: A review RK Singh, KM Lee, I Vujkovic-Cvijin, D Ucmak, B Farahnik, M Abrouk, ... Autoimmunity reviews 15 (4), 397-404, 2016 | 128 | 2016 |
| Monoclonal antibodies inhibiting IL-12,-23, and-17 for the treatment of psoriasis C Jeon, S Sekhon, D Yan, L Afifi, M Nakamura, T Bhutani Human vaccines & immunotherapeutics 13 (10), 2247-2259, 2017 | 114 | 2017 |
| The impact of pediatric atopic dermatitis on families: a review EJ Yang, KM Beck, S Sekhon, T Bhutani, J Koo Pediatric dermatology 36 (1), 66-71, 2019 | 106 | 2019 |
| The gut microbiome in psoriasis and psoriatic arthritis B Myers, N Brownstone, V Reddy, S Chan, Q Thibodeaux, A Truong, ... Best Practice & Research Clinical Rheumatology 33 (6), 101494, 2019 | 104 | 2019 |
| Psoriasis risk factors and triggers EB Lee, KK Wu, MP Lee, T Bhutani, JJ Wu Cutis 102 (5S), 18-20, 2018 | 91 | 2018 |
| Frequency and management of sleep disturbance in adults with atopic dermatitis: a systematic review C Jeon, D Yan, M Nakamura, S Sekhon, T Bhutani, T Berger, W Liao Dermatology and therapy 7, 349-364, 2017 | 89 | 2017 |
| Biologic treatments of psoriasis: an update for the clinician ND Brownstone, J Hong, M Mosca, E Hadeler, W Liao, T Bhutani, J Koo Biologics: Targets and Therapy, 39-51, 2021 | 87 | 2021 |
| Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer J Liu, HW Chang, ZM Huang, M Nakamura, S Sekhon, R Ahn, ... Journal of Allergy and Clinical Immunology 147 (6), 2370-2380, 2021 | 86 | 2021 |
| Ixekizumab for the treatment of psoriasis: a review of phase III trials B Farahnik, K Beroukhim, TH Zhu, M Abrouk, M Nakamura, R Singh, ... Dermatology and therapy 6, 25-37, 2016 | 84 | 2016 |
| A review of dupilumab in the treatment of atopic diseases Q Thibodeaux, MP Smith, K Ly, K Beck, W Liao, T Bhutani Human vaccines & immunotherapeutics 15 (9), 2129-2139, 2019 | 83 | 2019 |
| Warfarin-associated nonuremic calciphylaxis WYH Yu, T Bhutani, R Kornik, LB Pincus, T Mauro, MD Rosenblum, ... JAMA dermatology 153 (3), 309-314, 2017 | 82 | 2017 |
| Diagnosis and screening of patients with generalized pustular psoriasis K Ly, KM Beck, MP Smith, Q Thibodeaux, T Bhutani Psoriasis: Targets and Therapy, 37-42, 2019 | 81 | 2019 |
| Dupilumab treatment for generalized prurigo nodularis KM Beck, EJ Yang, S Sekhon, T Bhutani, W Liao JAMA dermatology 155 (1), 118-120, 2019 | 80 | 2019 |
| Brodalumab for the treatment of psoriasis: a review of phase III trials B Farahnik, K Beroukhim, M Abrouk, M Nakamura, TH Zhu, R Singh, ... Dermatology and therapy 6, 111-124, 2016 | 73 | 2016 |
| Anti IL-17 in psoriasis K Ly, MP Smith, Q Thibodeaux, V Reddy, W Liao, T Bhutani Expert review of clinical immunology 15 (11), 1185-1194, 2019 | 72 | 2019 |
| Guselkumab for the treatment of psoriasis: a review of phase III trials M Nakamura, K Lee, C Jeon, S Sekhon, L Afifi, D Yan, K Lee, T Bhutani Dermatology and therapy 7, 281-292, 2017 | 71 | 2017 |
| The role of the nervous system in the pathophysiology of psoriasis: a review of cases of psoriasis remission or improvement following denervation injury TH Zhu, M Nakamura, B Farahnik, M Abrouk, K Lee, R Singh, ... American journal of clinical dermatology 17, 257-263, 2016 | 69 | 2016 |
| Quality-of-life instruments: evaluation of the impact of psoriasis on patients MM Heller, JW Wong, TV Nguyen, ES Lee, T Bhutani, A Menter, JYM Koo Dermatologic clinics 30 (2), 281-291, 2012 | 65 | 2012 |
